About Us

About UsManagement

Andrea Recordati - Chief Executive Officer 

Andrea Recordati gained a Bachelor of Arts in medieval and modern history from the University of London Royal Holloway and Bedford New College. Between September 1995 and March 1998, he participated in the SmithKline Beecham Management Access Program, in the United Kingdom, starting off as Assistant Product Manager in Consumer Healthcare and then, for one year, occupying the role of medical representative in Essex before becoming Project Manager responsible for the development and implementation of an innovative SmithKline Beecham marketing initiative. He joined Recordati in 1998 as Project Leader for a project aimed at improving Sales Force productivity and better use of marketing investments. In April 1998, he joined the Board of Directors of the Company. In 1999, he was given responsibility for Pharmaceutical Business Development. In March 2002, the Lercanidipine Business Unit was set up and he was appointed head of that unit. Since November 2002, he has been responsible for setting up the subsidiary Recordati Ireland and its industrial plant and, subsequently, for setting up the UK subsidiary. In August 2007, the Northern and Central Europe Subsidiaries Division was set up and he was appointed head of that division. That division was enlarged in 2010 to include all western European companies. In February 2011 he was appointed General Manager of the International Pharmaceuticals Division. In 2013 he was appointed Chief Operating Officer, being responsible for all the commercial and production activities of the Group. In 2016 he was appointed Vice Chairman and Chief Executive Officer and from February 2019 he holds the position of  Chief Executive Officer.

Fritz Squindo - Group General Manager 

Fritz Squindo graduated “cum laude” in Economics at the Bocconi University in Milan, Italy. He started his career in 1981 in Telettra S.p.A., a telecommunications company within the Fiat Group, where he was employed in the finance department. In 1986 he joined Sanofi S.p.A., the Italian subsidiary of the French pharmaceutical group Sanofi, where he was first Head of Finance and, as from 1990, Head of Management Accounting. In 1992 he joined Recordati S.p.A. as Head of the Management Accounting department. In 1995 he was appointed Chief Financial Officer and in 2008 also became Managing Director. In November 2019 he was appointed Group General Manager. Since 2013 Mr. Squindo is a member of the Board of Directors of Recordati S.p.A. and is also part of the managing bodies of several Recordati Group companies

Enrico Baroncia - General Manager Pharmaceuticals Italy, Specialty & Primary Care

Enrico Baroncia holds a degree in Biology and has twenty years of experience in the pharmaceutical industry. After his initial experience as Sales Representative at Menarini, in 1995 he joined PHT as Business Development Manager and then he moved to Stroder, Servier Group, as Product Manager in the cardiovascular area. In 2000 he became Business Line Manager at Schering Plough in the interventional cardiology sector,  after which he joined GE Healthcare as Commercial Director , in charge of marketing, sales and business development for Italy and Greece in the diagnostic imaging business; in 2005, he joined Johnson & Johnson Medical as Sales Director. In 2007, Mr. Baroncia moved to Mylan, where he covered different positions with growing responsibilities: Business Director responsible for marketing and sales in retail and hospital channels, General Manager Mylan Italy and finally, as of 2013, President Mylan Europe, in charge of managing commercial, finance and business development operations. In Octobel 2013 joined Recordati as General Manager Italy.

Corrado Castellucci - Executive VP Rare Diseases Business Unit 

After earning a degree in medicine, Corrado Castellucci pursued his management training in marketing and general management. He began his career in the pharmaceutical industry in 1986 in the sales force of Hammer Pharma. In 1988 he joined Lepetit (which became Hoechst Marion Russel, which subsequently merged with Aventis Pharma Italy). He held positions of increasing responsibility and became Director of Marketing, Medical and Business Operations. In 2004 he joined AstraZeneca, where he ran both the hospital and oncological business units, before becoming Director of the entire Specialty Care Division. After his role as CEO, first with Gilead Sciences Italy (from 2007) and then with the pharmaceutical manufacturing companies NerPharMa and NerpharmaDS, he became General Manager in 2010 of Adienne, a pharmaceutical and biotechnology company whose primary focus area is onco-haematology with particular dedication to the treatment of rare and severe diseases. He joins Recordati in April 2013 as Vice President and Director for the Orphan Drugs Business.

Federica De Medici - Director Investor Relations & Corporate Communications 

Federica De Medici has a degree in Economics and Business from the Università degli Studi di Pavia and has spent more than twenty years in Investor Relations, both in Advisory firms and in listed companies.
In 1997 she started her professional career as Audit Consultant at KPMG, then becoming Senior Consultant in Transaction Service Department, focused on M&A. In 2000, she started her path in Investor Relations in Barabino & Partners, consulting firm specialized in Investor Relations and Financial Communication, as Advisor to Italian listed companies on IR plans supporting IPO’s, takeovers bids, capital increases.
In 2003, she joined RCS MediaGroup where she covered different positions with growing responsibility: she was first, Head of Investor Relations, in charge of the setup and the development of the related department, then Digital Strategy and Intelligence Director and finally Group Investor Relations Director.
In 2016 she moved to Wind Tre as Group Investor Relations Director, in charge of fostering the relationship with investor community, financial markets and rating agencies, and taking later on also the responsibility of the Business Intelligence and Market Research Department.
In October 2020 she joined Recordati as Director Investor Relations & Corporate Communications.

Gabriele Finzi - VP Corporate Development & Licensing

​Gabriele Finzi holds a degree in Business Administration with major in Corporate Finance from the Bocconi University (Milan). After an initial experience in investment banking, he began his corporate career as an M&A Analyst at Barilla, where he took part in a number of deals. In 2005, he joined Siemens Italy to set up the local M&A department; subsequently he became responsible for the financial planning of the South West Europe region of Siemens Medical Solutions. In 2008 he joined the Corporate Development department at Recordati where he has been assigned increasing responsibilities and has completed several acquisitions; he was appointed Group Business Development Director in 2012 and Vice President Corporate Development in 2016. Since 2019 he takes the responsibility also for the Licensing activities of the Group, in the role of Vice President Corporate Development & Licensing.

Daria Ghidoni - VP Corporate Legal Counsel 

Daria Ghidoni was awarded a degree in law with the highest grades from the Università Cattolica del Sacro Cuore of Milan and she is qualified in Italy. She began her career in 1995 with the law and tax firm Studio Associato Legale e Tributario (a correspondent of Ernst & Young International), where she worked as a legal adviser to major Italian and multinational companies mainly in the area of company law and commercial contracts. She continued her career in 2000 in the legal and corporate affairs office of the multinational group Giochi Preziosi, where she worked mainly on international contracts and mergers and acquisitions. In 2002 she joined Recordati as Head of Legal Affairs at the Parent Company and she was appointed to her present position as Head of Corporate Legal Affairs for the Group as a whole in 2011

Giuseppe Gualazzini - Senior VP Group Human Resources 

Giuseppe Gualazzini has more than thirty years of experience in international human resources management: after initial activity at IBM, he worked in Organizational Development at AGIP (ENI Group), Organization at Alivar (SME Group) and Staffing & Development at Boehringer Ingelheim; in 1989 he joined GE Medical Systems Italy (General Electric Group) as Staffing and Development Manager, then he became Plant HR Manager, Country HR Manager and finally, in 1995, he was appointed Region Human Resources Manager for Italy, Greece and Turkey. In GE Group he was involved in all European HR projects of the Medical Systems business.

In 1996 he moved to Deutsche Post DHL Group, where he covered different positions with growing responsibilities: he was first Region Human Resources Manager for Italy, Greece and Bulgaria in Danzas Group; he became Human Resources Director Italy, managing all the business units, in DHL Group, then he was Human Resources Director Mediterranean Area – Italy, Greece, Malta e Cyprus – for DHL Express Business Unit; finally, in 2007, he was appointed Vice President HR Middle East and Africa Region for DHL Global Forwarding Business Unit. In Deutsche Post DHL Group he played an active role in development and implementation of all the worldwide HR projects and was Member of the Executive Committee in charge of Group industrial relations at European level.

Finally, in May 2011, he joined SIRTI Group as Group HR Director; as of the 1st May 2014 he joined Recordati as Vice President Group HR.

Miguel Isla - VP Pharmaceuticals Western Europe Subsidiaries, Specialty & Primary Care

Miguel Isla Rodriguez has a PhD in Veterinary Medicine and a Master in Business Administration. He worked for twenty years at Pfizer with worldwide as well as country specific responsibilities. After covering different management roles in Pfizer’s Animal Health Division, where he became Global Director of Marketing, in 2003 he moved on to Pfizer Spain, first as National Sales Manager of the Pharmaceutical Division and then as Government and Public Affairs Director. In 2009 he was appointed as General Manager of Pfizer Spain. In September 2010 he joined Recordati as General Manager of Recordati España, the Spanish Subsidiary of the Group, and in December 2016 he became responsible for the International Primary and Specialty Care Business Unit and finally, in January 2021, Vice President Western Europe Region.

Luigi La Corte - Group Chief Financial Officer 

Luigi La Corte has a degree cum laude in Economics and Business (with major in Economics) from LUISS University in Rome and a professional qualification as Fellow of the Chartered Institute of Management Accountants; he has a wide experience in international finance roles, a large part of which spent in the pharmaceutical industry.
In 1993 he started his professional career at Procter & Gamble, where he covered different financial positions with growing responsibilities: Financial Analyst in Belgium, Capital Markets Manager at regional level and finally Group Manager Financial Planning and Analysis for the Nordics. In 1998 he moved to PepsiCo as International Corporate Finance Manager, to support Europe and Middle East businesses. After some years as Consultant at Bain & Company Italy, in 2004 he moved to Alliance Unichem’s pharmaceutical wholesaler and distribution business in Italy as Finance & Administration Director.
In 2005 he joined AstraZeneca as Chief Financial Officer of the Italian Subsidiary, becoming Regional Finance Director for the Asia-Pacific region and finally being appointed VP Finance for Global Commercial Organization, and subsequently taking on financial responsibilities for the Global Product & Portfolio Strategy Unit.
In 2014 he joined GlaxoSmithKline as SVP Finance for the global Pharma R&D organization, taking later on also the responsibility of Head of Global Business Development. Finally, in 2017, he joined pladis group, a leading snack and confectionary company, as Chief Financial Officer.
In November 2019 he joined Recordati as Group Chief Financial Officer.

Alberto Martinez - Executive VP Specialty & Primary Care Business Unit

Alberto Martinez has a PhD in Pharmacy and an Executive MBA with about twenty years of experience in the pharmaceutical industry.
After the initial activity as Sales Representative and Product Manager at Janssen, in 2003 he joined Mundipharma, where he covered different positions with growing responsibilities both at local and European level: he started his professional path as European Product Manager becoming, in 2006, European Marketing Manager.
One year later he was appointed General Manager at Mundipharma Spain, then widening his responsibilities to Portugal, As of 2014, he was at the same time Managing Director at Napp Pharmaceuticals in UK and Regional Director Northern Europe Mundipahrma.
In 2016, he was appointed European Director Commercial Operations and finally, one year later, President and Chief Executive Officer Europe, with global responsibility including R&D, manufacturing and supply chain.
In January 2021 he joined Recordati as Executive Vice President Specialty and Primary Care Business Unit.

Giovanni Minora - Group Audit & Compliance 

Giovanni Minora holds a degree in Business Economics from the Bocconi University of Milan. He started his professional career in 1995 as junior controller at Alcanital Services, then he worked at Alcan Alluminio as assistant to the financial manager. In 2000 he pursued a career in management in the auditing field: he was appointed Senior Internal Auditor at Foster Wheeler Italiana and later he joined Edison as Operations Auditing team coordinator. In 2005 he joined IT Holding S.p.A as head of Audit and Internal Control for the group. He joined Recordati in 2007 and is currently Director Corporate Auditing.

Scott Pescatore​ - VP Rare Diseases Global Operations

Scott Pescatore has a doctorate in Pharmacy and Oncology Drug Development with twenty years of experience in the pharmaceutical industry.
In 2001 after completing his post-doctoral fellowship at University of North Carolina Chapel Hill and GlaxoSmithKline, he joined Novartis Oncology where he spent most of his career covering different positions with growing responsibilities in Clinical Research, Sales & Marketing and General Management both in the US market, Global and at the European level.
In the US Oncology Business Unit he was Senior Clinical Research Scientist and then moved to commercial business becoming Senior Sales Specialist, Senior Manager Business Analytics and finally Senior Brand Manager Haematology for US and Global Marketing.
In 2008 he moved to the United Kingdom with Novartis Oncology as New Products Strategy Head and one year later was appointed Business Franchise Head of Oncology Solid Tumours. In 2010 he relocated to Italy as Marketing Director Region Europe for Haematology and in 2014 was appointed General Manager of the Oncology Business Unit in Ireland. In 2016 he was appointed General Manager Region Europe for the Rare Diseases Business Unit based in Italy. In 2018 after 17 years with Novartis Oncology, he joined AstraZeneca Italy as Vice President and Head of the Oncology Business Unit.
In February 2020 he joined Recordati as Vice President & Head of Global Operations Rare Diseases.

Cédric Ripert - VP Pharmaceuticals International Sales, Specialty & Primary Care

Cédric Ripert holds a degree in International Management from ESSCA and an Advanced Master in International Project Management from ESCP Europe in Paris, France. 
He started his career at Novartis France in strategic planning and business analysis roles in both Pharma and Consumer Health divisions. In 2006, he joined Basilea Pharmaceutica, headquartered in Basel, as Business Development & Licensing Manager, with focus on life-threatening infectious diseases. 
In 2011 he moved to Shire’s international headquarters, first as Global Business Insights Lead for the Hereditary Angioedema Franchise; then, in 2014, he was promoted Head of Distributor Business for Shire’s entire portfolio. He joined Recordati in November 2017 as Vice President, International Pharma Sales.

Raffaele Sabia - Senior VP Pharmaceutical Research & Development 

Raffaele Sabia holds a degree in Medicine and a post-graduate diploma in Cardiovascular and has a long and rich experience in R&D roles in the pharmaceutical business.
In 1990 he started his professional career at Schwarz Pharma as Medical Adviser for the Cardiovascular area and then became Clinical Research Manager.
In 1997 he moved to AstraZeneca, where he covered different medical roles with growing responsibilities: first he was Senior Clinical Adviser Cardiovascular Area, then Medical Manager Cardiovascular & Metabolic Therapy Areas, later on Medical Affairs Director Primary Care, Neuroscience & Hospital; in 2006 he became, at Headquarters level, European Medical Affairs Director for the Cardiovascular Area.
In the following year, as a part of the same Group, he came back to Italy as Vice President Medical, then Vice President Medical & Regulatory, and finally in 2012 Vice President Medical, Regulatory & Market Access, in charge of the management of Medical Affairs, Clinical Research, Drug Safety, Regulatory Affairs and Market Access Departments.
Finally, in 2013 he joined Novartis Headquarters as Medical Head Region Europe – Cardio Metabolic Franchise, in charge for the entire region of design and implementation of the strategic clinical development and medical affairs programs related to Cardio Metabolic compounds.
During his career he gained a significant experience in different therapeutic areas (Cardiovascular, Metabolic, Gastrointestinal, Respiratory, Neuroscience, Oncology, Anesthesiology, Anti-infective, Vaccines) and contributed to the success of several products. 
In July 2017 he joined Recordati S.p.A. as Director .Pharmaceutical Research and Development.

Roberto Teruzzi  - Executive VP Group Industrial Operations 

Roberto Teruzzi, who holds a degree in veterinary medicine and two international MBAs, has thirty years of experience in managerial roles in the pharmaceutical business.
In 1986 he started his professional career in Boehringer Mannheim, in R&D and then in Commercial area. He covered different roles with growing responsibilities in various pharmaceutical companies: as of 1989 he was International Product Manager at Farmitalia Carlo Erba, in 1992 he moved to Zambon as Business Development Manager and in 1994 he joined Pharmacia &  Upjohn as International Markets Manager.
In 1998 he was in charge of establishing the Italian subsidiary of Ratiopharm, becoming Managing Director of the Company. In 2005 he moved to Alliance Boots, where he established the Almus and Alvita Companies, for the commercialization of generics and para-pharmaceutical products in South Europe, becoming General Manager Europe Almus & Alvita and Managing Director of Almus Italy and Alvita Italy.
In 2008 he joined Mipharm as Chief Operating Officer, responsible for Commercial, Logistics, Distribution and R&D activities; after the transfer of commercial activities to Novartis he was in charge of the production plant, with main responsibility of maximizing profitability.
Finally, in 2010, he moved to Corvette Group (acquired by Recipharm in 2014) as Chief Executive Officer to coordinate Biologici Italia Laboratories, Edmond Pharma and Liosintex, companies operating in third parties manufacturing and development of pharmaceutical products as well as in commercial activities.
In April 2015 he joined Recordati as Executive Vice President of Group Industrial Operations.


Witold Urban - VP Pharmaceuticals Central and Eastern Europe Subsidiaries, Specialty & Primary  Care

Witold Urban earned a Master of Art in Modern History at University of Gdansk (Poland). After an initial experience in Sales at Sterling Health, in 1995 he joined SmithKline Beecham Consumer Healthcare, today part of GlaxoSmithKline Consumer Healthcare, where he worked for eighteen years with country and regional responsibilities in Central and Eastern Europe. After covering different sales and marketing roles in Poland, he became Sales Development Director for the CEE Area, then Country Manager Ukraine, Vice President & General Manager Poland and finally, in 2009, he was appointed Vice President & General Manager Russia and Head of CEE Corega (Denture Care). In 2012, Mr. Urban was appointed Director Business Development and Strategic Projects CEE. In July 2013 he joined Recordati  S.p.A. as Regional Director Central-Eastern Europe.

Ismail Yormaz - VP Pharmaceuticals South Eastern Europe Subsidiaries and North Africa, Specialty & Primary Care

Ismail Yormaz attended Ankara University, where he received a bachelor’s degree in medicine, and has M.B.A from Istanbul University. After an experience as Product Manager first in BASF Pharma and then in Abbott Laboratories, in 2002 he moved on to Menarini as Group Product Manager for Turkey. Before joining Recordati, he worked in Reckitt Benckiser, where he was Marketing and Sales Manager of Healthcare business. He joined Yeni Recordati in 2009 as General Manager. He managed the merge between the company and Dr. Frik Ilaç  that formed present-day Recordati Ilaç.  In 2014, he was appointed Regional Director South-Eastern Europe and North Africa.